Chemical industry – Page 35
-
BusinessPharmaceuticals roundup 2018
Merger deals, product approvals and infrastructure changes have been overshadowed by political uncertainty, in Europe and around the world
-
BusinessBayer to cut 12000 jobs
As it integrates Monsanto businesses, Bayer will eliminate around 10% of its global workforce
-
BusinessSartan drug contamination brings cancer uncertainty
Levels of nitrosamines and other carcinogens in affected tablets of valsartan and related drugs similar to smoking 20 cigarettes a day
-
BusinessSensing the sweet spot
Ziylo’s selective glucose-binding molecule could open doors to smart insulin for diabetes
-
BusinessArrests in China follow massive leak into the Taiwan Strait
Seven charged with criminal negligence after release of 70 tonnes of aromatic hydrocarbons sickened over 50 people
-
OpinionPushing the limits of patent protection
Some methods of extending exclusivity rights raise legal and ethical questions
-
BusinessBreaking the silence of RNA interference drugs
A wave of treatments is set to follow the first approval of an RNAi therapy
-
WhitepaperTesting for mosquito repellent residue
High-quality reference materials advance analyses, save time, and reduce costs
-
ReviewBitter Pills: The Global War on Counterfeit Drugs
Muhammad Zaman’s book gives an account of the challenges facing drug regulators worldwide
-
-
-
BusinessTransforming PET imaging with silicon
Fuzionaire Diagnostics can add Si–18F radiolabels to a variety of molecules quickly, easily and cheaply
-
OpinionWhat would a 1980s student make of modern research?
Nano- and macromolecular science might make for a shocking read in the launderette
-
BusinessLords criticise post-Brexit regulation plans
Current lack of preparedness risks ‘cliff-edge’ on exit day, committee warns
-
NewsAction plan launched to tackle gender inequality and bullying in chemistry
Bullying helpline and childcare grants among measures outlined in Royal Society of Chemistry report that reveals why chemistry has an equality problem
-
OpinionPassing through checkpoints
A new breed of cancer treatments highlights what’s possible when industry concentrates its efforts
-
ResearchWaste vegetable oils turned into chemicals for drugs and plastics
Dual catalytic system converts complex carboxylic acids into terminal alkenes
-
BusinessSmall biocides companies face uncertain fate
Cost and complexity of European law hampers innovation and excludes SMEs
-
BusinessCancer immunotherapy spreads rapidly
New approvals and expanded use for checkpoint inhibitor drugs illustrate the power of Nobel-winning science
-
